Anthraquinone → 4-[(3-aminopropyl)amino]-1-[(3-L-phenylalanylaminopropyl)-amino]-anthracene-9,10-dione

HRID 3083

Reaktionsgleichung

Reaktionsgleichung von HRID 3083
C1C2C(=O)C3C(=CC=CC=3)C(=O)C=2C=CC=1.[NH2:17][CH2:18][CH2:19][CH2:20][NH:21][C:22]1[C:35]2[C:34](=[O:36])[C:33]3[C:28](=[CH:29][CH:30]=[CH:31][CH:32]=3)[C:27](=[O:37])[C:26]=2[C:25]([NH:38][CH2:39][CH2:40][CH2:41][NH2:42])=[CH:24][CH:23]=1.C(OC([NH:50][C@H:51]([C:59](O)=[O:60])[CH2:52][C:53]1[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=1)=O)(C)(C)C.C(OC(NCC(O)=O)=O)(C)(C)C>>[NH2:42][CH2:41][CH2:40][CH2:39][NH:38][C:25]1[C:26]2[C:27](=[O:37])[C:28]3[C:33](=[CH:32][CH:31]=[CH:30][CH:29]=3)[C:34](=[O:36])[C:35]=2[C:22]([NH:21][CH2:20][CH2:19][CH2:18][NH:17][C:59](=[O:60])[C@H:51]([CH2:52][C:53]2[CH:54]=[CH:55][CH:56]=[CH:57][CH:58]=2)[NH2:50])=[CH:23][CH:24]=1

Komponenten

5

Versuchsvorschrift

Example 29 was prepared by an equivalent procedure to that described for Example 24 except that the starting anthraquinone was 1,4-bis[(3-aminopropyl)amino]-anthracene-9,10-dione and N-tertiarybutoxycarbonyl-L-phenylalanine replaced N-tertiarybutoxycarbonylglycine.

Aufarbeitung

  1. customExample 29 was prepared by an equivalent procedure to that

Quellen und Nachweise

ORD-Eintrag
ord-5825bb94a6c044969c60477a29132a82
Quelldatensatz
uspto-grants-1998_03
Patentnummer
US05733880

Verknüpfte Notizen

Wird geladen…